In this review, we explore some aspects of Pseudomonas aeruginosa virulence factors that are related to disease development in healthy organisms and resistance to antibiotics. This pathogen is one of the most clinically and epidemiologically important bacteria in Brazil, being the major cause of opportunistic infections. Among the virulence factors, biofilm formation acting of manner different in the organism. Furthermore, we review several P. aeruginosa genes that act in antimicrobial resistance, such as β-lactamases against β-lactamers. The resistance to pied-lactamases in P. aeruginosa is associated to resistance to the broad-spectrum cephalosporin. On the other hand, there is a group of synthetic broad-spectrum antibiotics acting on DNA synthesis is the quinolones that destroy HIGHLIGHTS  The bacterium has become the most antibiotic-resistant hospital disease  P. aeuroginosa developed a mechanism antimicrobial against classes of β-lactamases Rocha, A.J.; et al. www.scielo.br/babt the microorganism. We also explore the occurence of super bacterium: P. aerufinosa carrying genes blaKPC and blaNDM, which are associated with patient death above the average of other bacterial infections in hospitals. Those genes encode carbapenemases that can potentially hydrolyse all β-lactam antibiotics
of causing several deseases invading the organism and its immune system leading infecctions nearly impossible to eradicate [10] [11] [12] . Among the pathogenicity caused by virulence factors, can be cited Lipopolysaccharide, Flagellum, Type IV Pili, Type III Secretion System, Exotoxin A, Proteases, Alginate, Quorum Sensing, Biofilm Formation, Type VI Secretion Systems, Oxidant Generation in the Airspace. These are major virulence factors acting in different manners in the immune system.
The LPS is a predominant component of the outer membrane of P. aeruginosa. Bacterial LPS typically consists of a hydrophobic domain known as lipid A (or endotoxin), a non-repeating core oligosaccharide, and a distal polysaccharide (or O-antigen) [13] . LPS plays a prominent role in the activation of the host's innate (TLR4, NLRP1, NLRP2, and NLRP3) and adaptive (or acquired) immune responses; and, eventually causes dysregulated inflammation responses that contribute to morbidity and mortality [14] .
In relation to virulence factors, the type IV pili of P. aeruginosa has a role in adhesion to many cell types and this is likely important in such phenomena as tissue tropism and attachment to particular tissues. The initiation of biofilm formation and non-opsonic phagocytosis ismediated by phagocyte receptors that recognize corresponding adhesions on microbial surfaces [15] [16] [17] [18] [19] . However, the virulence factors of Type III Secretion System provide a variety of secretion systems of which at least four likely play a role in virulence (Type I, II, III, and IV). The T3SS is one of the most intriguing virulence factors that involves a flagellum-basal-body related system for delivering proteins directly from the cytoplasm of P. aeruginosa into the cytosol of host cells that contributes to evasion of phagocytosis by P. aeruginosa as well as damage to host tissues, promoving a immune avoidance and bacterial dissemination (20, 21) .
The virulence factors exotoxin A are secreted through Type II secretion mechanism, which use a pilus-like apparatus to secrete proteins into the extracellular environment, including lipase, phospholipase, alkaline phosphatase and protease. Animal experiments have indicated the significant role of these factors in model infection [22] . Besides, exotoxin A has been demonstrated to be involved in local tissue damage and invasion [23] .
Several proteases produced by P. aeruginosa as metaloproteases of type elastase LasB destroy host tissue; thus, it plays a significant role in both acute lung infections and burned wound infections [24] . Already the virulence factors alginate can produce a mucoid exopolysaccharide capsule, comprised of alginate, an acetylated random co-polymer of β 1-4 linked D-mannuronic acid (poly-M) and L-guluronic acid [25] . The evidence of playing this role isbelieved due the overproduction of alginate in cell adherence within the CF lung and is thought to be involved in resistance to host defense by reducing susceptibility to phagocytosis [26] .
The virulence factor Quorum sensing is a mechanism of bacterial "cell-to-cell" communication via diffusible chemical compounds. The Quorum is required to produce a sufficient amount of a secreted signal molecule (termed an autoinducer) to trigger expression of a large regulon [27] . In regarding to autoinducer, the most common class isused by Gram-negative bacteria and acyl-homoserine lactones (AHL). The mechanism is diffuse freely across bacterial membranes. AHL signals produced by P. aeruginosa are oxohexanoyl-homoserine lactone and butanoyl-homoserine lactone (28, 29) . The AHL signals produced by AHL synthase (LasI/RhlI) are diffused into the environment. The increase of bacterial density during infection leads to an increase in autoinducer concentration. In a determinated moment, autoinducer reaches a particular threshold and subsequently binds to transcriptional activator (LasR/RhlR) that forms a complex that activates genes involved in biofilm formation and coding virulence factors [30] . Biofilm formation starts with the attachment of free-swimming bacteria (planktonic) to a surface via their type IV pili and flagellum, followed by twitching motility and the formation of microcolonies; then quorum sensing signals begin to accumulate. Once a critical threshold of quorum sensing signals is reached, microcolonies become encased in an extracellular matrix [31] In this review was described the biofilm formation that is also a virulence factor in the first topic. However, the last virulence factor discussed here is the Type VI Secretion Systems. Bacterial pathogens frequently possess numbers of secretion systems that function to translocate protein secretion. The T6SS represents one of the most recently recognized examples of these secretion systems. An interest in T6SS has led to its rapid study in P. aeruginosa in term of structure, mechanical function, assembly, and regulation of secretion P. aeruginosa T6SS provides defense against other bacteria in the environment [31] [32] [33] The Pseudomonas aeruginosa: the formation of the biofilm and resistance of the biofilm and free-live to antimicrobial
Biofilms are communities composed of microorganisms adhered to a biotic or abiotic surface surrounded by a matrix of exopolysaccharide (EPS), whose function is to guarantee the protection of the microorganisms existing in its interior against the attack of the microbial aggressions of the external or internal environment. Thus, when P. aeruginosa is submitted under stress conditions, the formation of biofilms are often associated with higher antimicrobial resistance when compared to the planktonic form and assists in the evasion of the host immune response (31) (32) (33) (34) (35) (36) . Biofilm microorganisms also exhibit altered phenotype with respect to growth rate and gene transcription [35, 35] . P. aeruginosa is a Gram-negative bacillus involved in opportunistic diseases, particularly in immunocompromised patients, which may cause several diseases as dermatitis, urinary infections and a wide variety of systemic infections, especially in hospital infections [36] . The pathogenicity caused by P. auruginosa is a result of its phenotypic adaptability and its high degree of genomic flexibility. This microorganism increases its pathogenicity and synthesis of virulence factors. The P. aeruginosa is exposed to stress conditions and changes occur in its growth mode, generating biofilms (37) . Thus, in promoting the growth of bacterial populations collectively, biofilms provide the species with adaptive mechanisms, such as the ability to synthesize signaling substances that mediate biofilm behavior as well as the synthesis of genes involved in protetion against antimicrobial, to adapt and become resistent to antimicrobial developed by the pharmaceutical industry. (37) .
Mechanism of action of essential genes against antimicrobial activities
Several mechanisms were developed by the P. aureginosa in order to be resistent to antimicrobial activities.Among β-lactam resistance mechanisms, the most important process is the production of β-lactamase enzymes; however, resistance can also be caused by hyperexpression of efflux systems, alteration of membrane permeability, as well as the synthesis of penicillin binding proteins (PBPs) with low affinity for β-lactams. In P. aeruginosa, all these mechanisms can exist simultaneously or isolated.
Mechanism of potential genes target of P. aeuriginosa against β-lactamers antimicrobial
The pathogen P. aeuroginosa developed a mechanism antimicrobial against classes of β-lactamases [38] and a significant number of different classes are found in P. aeruginosa. The β-lactamases are capable of inactivate the β-lactam antimicrobials by ring breaking β-lactam, disrupting its amide bond, so the products obtained cease to have antibacterial activity as showed in figure 1 [39] . The hydrolysis of antibiotics by the β-lactamase activity occurs by the formation of an ester bond between the active serine site (or with zinc ions in the case of the metallo-β-lactamases) of the β-lactamase enzyme and the β-lactam ring of the antimicrobial [39, 40] The enzymes of the P. aeruginosa that break the β-lactam ring are located in the periplasmic space and inactivate β-lactams, in which pass through the outer membrane, Brazilian Archives of Biology and Technology. Vol.62: e19180503, 2019 www.scielo.br/babt before they reach the PBPs. (Livermore et al, 2002) . Several genes encoding β-lactamase enzymes are located in mobile regions of bacterial DNA, such as plasmids and (class 1 integrons, however some are found in the class 2 and 3 integrins) [38] [39] [40] .
The β-lactamases class of genes encoding specific enzymes of Pseudomonas aeruginosa (PSEs)
The β-lactamases are the specific enzymes of Pseudomonas (PSEs) PSE-1 and PSE-4. In Ambler's class A, within Bush's functional group 2c, four PSE-type β-lactamases that hydrolyze carbenicillin were found in P. aeruginosa: PSE-1 (CARB-2), PSE-4 (CARB-1), CARB-3 and CARB-4; its substrate of PSEs includes several antimicrobial as carboxypenicillins, ureidopenicillins and cefsulodine. The presence of PSEs can be bypassed, since strains producing carbenicillinases present variable susceptibility to cefepime, cefpirome and aztreonam and total susceptibility to ceftazidime and carbapenems [37] [38] [39] . Genes similar to PSE-4 are part of transposons containing several genes that are encoding enzymes of the resistance that encodes PSE-4 enzymes.
Strateva et al [38] also concluded that to PSEs, broad-spectrum β-lactamases (ESBLs) of molecular class A and functional group 2b 'lead to the development of resistance not only to carboxypenicillins and ureidopenicillins, but also to broad spectrum efalosporins. These enzymes may have a wider hydrolytic activity, including over carbapenems, although almost all are inhibited by clavulanic acid. The frequency of ESBLs, widely reported in enterobacteria, has increased in P. aeruginosa isolates.
On the other hand, there is an ezyme encondig the gene AmpC of Ambler's class A denominated cephalosporins. This occurs by the superexpression in the bacteria causing stable derepression; this mechanism is frequently responsible for resistance to third generation cephalosporins. The resistance to pied-lactamics in P. aeruginosa is associated to resistance to β-lactamics and this antmicrobial big spectrum as cefalosporins. Β-lactamase inhibitors in clinical practice, such as clavulanic acid, sulbactam and tazobactam (Livermore et al, 2002) , do not inhibit the activity of AmpC.
Strateva et al, [38] also investigated that other type of Class D β-lactamases is constituted by ESBLs of type OXA-18, OXA-2, OXA-10 (PSE-2), OXA-21, ARI-1 (Acinetobacter Resistant to Imipenem). The classical OXA (OXA-1, OXA-2, OXA-10) enzymes determine resistance to carboxypenicillins and ureidopenicillins, but not to ceftazidime. Therefore, oxacillinases that hydrolyze ceftazidime have the highest clinical importance. Its hydrolytic spectrum also includes cefotaxime, cefepime, cefpirome, aztreonam and moxalactam.
With the exception of OXA-18, which is totally inhibited by clavulanic acid and whose hydrolytic properties resemble those of class A ESBLs, β-lactamase inhibitors do not suppress the activity of these enzymes. Although the β-lactamases of Ambler families A, C and D use a serine residue as nucleophile for catalysis, the metallo-β-lactamases (MβLs), inserted into class B of Ambler and class 3 of Bush-Jacoby-Medeiros, use divalent cations, generally, Zn +2 , as cofactor for their catalytic activity. Another characteristic that differentiates MβLs from serine-β-lactamases is the low susceptibility to β-lactamase inhibitors (tazobactam, sulbactam and clavulanic). Furthermore, MβLs that have activity Brazilian Archives of Biology and Technology. Vol.62: e19180503, 2019 www.scielo.br/babt against carbapenems do not hydrolyze monobaccharides, such as aztreonam are inhibited by chelating agents [39] [40] .
Ciprofloxacin and resistance mechanisms
Quinolones are a group of synthetic broad-spectrum antibiotics acting on DNA synthesis to destroy the microorganism. They have been widely used for the treatment of intra-and extra-hospital infections, making it a very important resource for developing countries because of the high availability of generics that drastically reduce the cost of treatment [34, 41] .
The specific target of the quinolones occurs through the interference of DNA synthesis, leading to bacterial cell death by chromosome fragmentation. It penetrates into the cell wall through porins, directly inhibiting bacterial replication. The interacting with two enzymes: DNA-gyrase (tetrameric protein composed of two pairs of A and B subunits encoded by GyrA and GyrB genes) and topoisomerase IV (tetrameric protein composed of two pairs of subunits A and B encoded by parc and Par E genes), both are required to perform DNA supercoiling. Thus, specifically, DNA-gyrase is the primary target in Gram-negative bacteria, whereas topoisomerase IV is in Gram-positive bacteria. However, there are quinolones with enhanced activity and potency spectrum and appear to target both enzymes (42) (43) .
There are different mechanisms of resistance in quinolones; the main ones for Gram-negative, as P. aeruginosa: 1) mutation in target sites / regions quinolone resistance-determining region (QRDR), 2) transmission of plasmid resistance genes, called plasmid (3) changes in membrane permeability and (4) efflux mechanism (Fig. 2) [44] [45] [46] . Thus, the antibiotic of the quinolone class that has shown the greatest resistance to Gram-negative is ciprofloxacin. Even after 20 years of launch and success, it remains the most prescribed and recommended in the treatment of community urinary tract infections, and therefore, the most exposed to these bacteria [45] [46] . However, its use on a large scale can generate problems not only with regard to the resistance acquired by pathological microorganisms during a clinical treatment, but also represent a significant risk to the environment [47, 48] .
The substance ciprofloxacin, wich has the chemical name of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl) -3-quinoline carboxylic acid hydrochloride, has its chemical structure shown in figure 3 . In fluoroquinolones, the presence of the piperazino group confers antipseudomonas activity, whereas the fluorine atom increases the potency against Gram-negative species in general and broadens its action spectrum including Gram-positive species. Thus, they are active against a wide variety of 21 aerobic microorganisms. They are, therefore, broad-spectrum anti-infectives. However, they are generally inactive against anaerobic bacteria [50] .
Mechanism of potential genes target of P. aeuriginosa throug to Pump eflux
The most common form of resistance to most classes of antibiotics is throug pump antibiotics out of cells. [51] In P. aeruginosa, active efflux is an important non-enzymatic mechanism of resistance to β-lactams. In addition to antibiotics, biocides and detergents, these pumps export several other molecules. [51] The expression of efflux pumps is one of Brazilian Archives of Biology and Technology. Vol.62: e19180503, 2019 www.scielo.br/babt the mechanisms responsible for antimicrobial resistance in biofilms. [52] As presented in figure 4 . [55] . The multidrug efflux system of the RND type in P. aeruginosa, the MexABOprM, removes β-lactams, chloramphenicol, macrolides, novobiocin, sulfonamides, tetracycline etrimethoprim, as well as various dyes and detergents [56] . MexAB-OprM is the most common efflux system, and its overexpression results in resistance to quinolones, penicillins and cephalosporins.
De Kievit et al [54] , investigated the expression of genes associated with two multidrug resistance (MDR) efflux pumps, MexAB-OprM and MexCD-OprJ, throughout the course of biofilm development. Using fusions to GFP, we were able to analyze spatial and temporal expression of mexA and mexC in the developing biofilm. The results showed that the Brazilian Archives of Biology and Technology. Vol.62: e19180503, 2019 www.scielo.br/babt expression of mexAB-oprM and mexCD-oprJ was not upregulated but rather decreased over time in the developing biofilm.
Northern blot analysis confirmed that these pumps were not hyperexpressed in the biofilm. Furthermore, spatial differences in mexAB-oprM and mexCD-oprJ expression were observed, with maximal activity occurring at the biofilm substratum. Using a series of MDR mutants, assessed the contribution of the MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY efflux pumps to P.aeruginosa biofilm resistance. These analyses led to the surprising discovery that the four characterized efflux pumps do not play a role in the antibiotic-resistant phenotype of P. aeruginosa biofilms [10] . The position of the genes encoding the multiple efflux (mex) components of four characterized pumps (mexAB, mexCD, mexEF and mexXY) are shown together with their respective porin (opr) components, oprM and oprJ and oprN. The position of the chromosomal b-lactamase gene (ampC) and its regulatory gene (ampR) also shown in figure 5 below. All classes of antibiotics except the polymyxins are susceptible to extrusion by one or more of the efflux systems. MexAB-oprM is responsible for extrusion of b-lactams, quinolones and a range of disinfectants. MexXY-oprM extrudes aminoglycosides and mexEF-oprN extrudes carbapenems and quinolones. Besides, the genes for the systems are present in all strains, but they are not expressed at high levels. However, increased expression can result from mutation in regulatory genes such as mexR, which controls expression of the mexAB-oprM genes [55] [56] [57] [58] .
Vahaboglu et al, [56] has investigated beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. The result revealed that over-production of the ampC b-lactamase poses a particular threat to cephalosporins. Other b-lactamases produced by P. aeruginosa include extended-spectrum plasmid-mediated enzymes (ESBLs) active against penicillins and cephalosporins. Nevertheless, the use of b-lactamase inhibitors (clavulanic acid with ticarillin and tazobactam withPiperacillin) provides protection of these antibiotics against some of the plasmid-mediated enzymes, but not the ampC.
Taylor et al [57] has analysed the antibiotic resistance in Pseudomonas aeruginosa biofilms: Towards the development of novel anti-biofilm therapies e conclude in your work because of this highly adapted ability to survive in adverse environmental conditions, bacterial biofilms are recalcitrant to antibiotic therapies and immune clearance. This is particularly problematic in hospital settings where biofilms are a frequent cause of chronic and device-related infections and constitute a significant burden on the health-care system. These biofilms are able of expressing potential genes for increasing the resistance of P. auriginosa to attack of antimicrobial, leading to acquire an adaptive resistance that is becoming increasingly recognized as a clinical important mechanism of resistance to antimicrobial.
Zhang et al, [58] has identified involvement in P. aeruginosa with biofilm-specific resistance to antibiotics. The authors identified 3 genes or operons of P. aeruginosa UCBPP-PA14 (ndvB,PA1875-1877 and tssC1) that do not affect biofilm formation, but are involved in biofilm-specific antibiotic resistance. In this study, they demonstrated that PA0756-0757 is encoding a putative two-component regulatory system. PA2070 andPA5033 showed increased expression in biofilm cells. They also have a role in biofilm-specific antibiotic resistance. Furthermore, deletion of each PA0756, PA2070 and PA5033 resulted in a significant reduction of lethality in Caenorhabditis elegans, indicating a role for these genes in both biofilm-specific antibiotic resistance and persistence in vivo.
Super Bacteria: blaKPC and blaNDM genes
As a matter of course, since 2010, the Brazilian media has used the term "KPC superbug" (as well as "NDM superbug"). In the lay context, it refers to the bacteria that has caused deaths of patients above the average of other bacterial hospital infections, associated or not to outbreaks. Scientifically, in the clinical and microbiological context, as presented, KPC and NDM are carbapenemases (beta-lactamases enzymes) that have the potential for hydrolysis (degradation) of practically all beta-lactam antibiotics. The blaKPC and blaNDM genes have presented great potential for dissemination, characteristic associated with mobile genetic elements (eg plasmids) and high bacterial clones [59] [60] .
CONCLUDING REMARKS
Several groups of scientists have developed various drugs with varied mechanisms of action to combat the antimicrobial resistance caused by P. aeruginosa. The bacterium has become the most antibiotic-resistant hospital disease in the pharmaceutical industry. Due this problem, researchers have been trying to find new drugs capable of stopping the microbial infection caused by P. aeruginosa, which has shown resistance to most antibiotics. The challenge now is to reverse this clinical problem and eradicate the infection caused by P. aeroginosa with new drugs with potential antimicrobials capable of curing patients with this disease.
